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Atdmugh there have been significant advance in the care of many 
of the extrapancmatic manifestations of diabetes, acute myacer- 
dial infarction continues to be a major cause nf morbidily and 
mortality in diabetic palients. Factors unique to diabetes increase 
stberosclerotic plaque fm’mation and thrombosis, thereby con- 
tributlng to myaeardial infarction. Autonomic nsurapllby may 
predispose ta infsrrtion and result in atypical prsspnting symp 
twm in the diabetic patisnt, making diagnosis difficult and 
fr&a& complicated and csrriw a highs; mwtsltty rate in the 
diabetic than in the nondiabetic patient. Althawh the course and 
pnthophysialagy of myocardial h&lion d&r to some degree in 
diabetic patients from tbw in patients without diabetes, much 
more remalm to be knnwn to fmmulate more effsctivo treatment 
rlrntegirs in this high risk subgroup. 
(J Am CON Card&d 1992;20:736-44) 
Since the advent of insulin therapy, mortality due to diabetes 
mellitus has diminished considerablv. As morbiditv and 
mortality related to ketoacidosis and infections ha&z de- 
creased, coronary anery disease has assumed a dispropor- 
tionately larger responsibility for the morbidity and mortality 
experienced by patients with diabetes (I). Diabetic patients 
suffer from an excess of coronary artery disease and the 
course of acute myocardial infarction is often punctuated by 
complications in this group. There is a significant relation 
between diabetes mellilus and coronary vascttlar disease 
that creates important differences between the clinical 
course of acute myocardial infarction in these patients and 
that in patients wifhout diabetes. This review will discuss the 
diEerences in the epidemiology, pathophysiology and treat- 
ment of acute myocardial infarction in diabetic compared 
with oondiabetic patients. 
Epidemiology 
Mywardial infarction and cardiovascular mortality. Epi- 
demiologic data derived from the Frsmingham Heart Study 
demonstrate :he increased incidewe ef heart discsse in 
patients with diabetes and their poor prognosis. The cardio- 
vascular mortality rate is more tban doubled in men and 
more than quadrupled in women who have diabetes, com- 
pared with the rate in their nondiabetic counterparts (2). The 
relative risk of myocardial infarction is 5U% gie~ter in 
diabetic men and ISo% grealer in diabetic women. Similarly, 
diabetic men succumb to sudden death 50% more often and 
diabetic women 300% more often than do their age-matched 
nondiabetic counterparts (3). Acute myocardial infarction is 
said to account for as many ar 3U% of all deaths in diabetic 
patients (4). Among: those with insulin-dewndent diabetes, 
;he cumulative m&lily rate due to wron&y artery disease 
is 35% by we 55. far higher than the corresoondina rate of 
4% to S% for patients without diabetes cited in the &ming- 
ham data (5). 
Incidenw and extent of coronary artery d&se. Diabetes 
is ac independem risk factor for the development of core- 
nary artery disease (6). The overall prevalence of coronary 
disease, as assessed by various diagnostic methods, is as 
high BS 55% among adult patients with diabetes compared 
with ‘2% to 4% for the general population (6). Comnary 
atherosclerosis is not only more prevalent, it is also ciearly 
more extensive in diabetic than in nondiabetic patients (7). 
At coronary angiogmphy or autopsy, patients with diabetes 
have a higher incidence of double- and triple-vessel disease 
and a lower incidence of single-vessel disease than those of 
their nondiabetic counterparts (68). The incidence of severe 
left main coronary disease is also significantly higher (13% 
vs. 6%) in diabetic than in nondiabetic patients (9). In one 
large autopsy study, Yl% of patients with adult onset diabe- 
tes and no known coronary heart disease had severe narrow- 
isg of at least one majorcoronay srtery and 63% had severe 
Iflo- or three-vessel involvement (9). In a group of adtdts of 
similar age without overt diabetes or known coronary heart 
disease, only 33% had severe single-vessel coronary nuxwv- 
ing and 17% had severe two- or three-vessel disease at 
autopsy (IO). Whether coronary atherosclerosis is actually 
more “diffuse” or is merely expressed as a greater number 
of discrete stenoses is the subject of some debate (9,l I). In 
the autopsy study mentioned, diabetic patients who dsed of 
coronary artery disease had more sknoses than did nondia- to be a risk factor for atherogenesis. Hypnnculinernia even 
betic patients but the appearance of other arterial segments in the pre~enc- If normal glucose tolerance is associated 
was similar between the two groups. However. another with an increase m risk factors for coronary artery disease 
autopsy study found that patients with juvenile onset diabe- including low HDL cholesterol evels and hypertension (22). 
tes had a more diffuse fortn of coronary artery disease with Hypcrmsulinemia may also play a role in promoting athero- 
at least half of the overall lenglh of the epicatdial coronary stierobts by causing smooth muscle celi proliferatwn and 
arteries narrowed by ~50% whereas in nondiabetic oatients cholesterol synthesis and by increasing levels of growth 
<I% of the length was similarly involved (12). hormone (23). Hyp@ycemia atone has been suggested as a 
risk factor for athciosclerosis. though the level of hypergly- 
cemia itself is not an indeoendent risk factor for the devel- 
Factors Favoring Myocardial Infarction in 
Patients With Diabetes 
opment of co~onaty artery disease. 
Patients wnh diabetes have elevated plasma and whole 
blood viscosity due to high levels of plasma proteins and 
Acute infarction most often involves in!errup:ion of myo- increased red cell aggregation and possibly decreased red 
cardial blood Row due to underlying atherosclerotic plaque cell deformability (24.25). These effects are particularly 
with further lumen compromise by thmmbus (13). Pmgres- evident during periods of metabolic derangement such as 
sion of atherosclerosis may occur through repeated plaque diabetic ketnacidosis and appear to be improved with better 
rupture and thrombosis in a repetitive cycle of injury and glycemic control. Increased shear forces due to high vixos- 
healing that results in lumen narrowing (14). Diabetes is ity could enhance a tendency toward plaque rupture. In 
associated with an increased propensity for both atheroscle- addition. these rheologic effects could contribute to infarct 
rotic plaque formation and intraluminal thrombosis. which extension by impeding collateral coronary blood flow, per- 
may increase the likelihood of infarction. titularly in areas with low blood Row at baseline. 
Aeeekrated athercsderosis and plnqw rupture. Elevated 
serum lipid levels induce vascular damage and promote 
athemsckmsis. Pathologic studies of coronary vessels in 
patients after infarction indicate that lipid-rich plaques may 
be more likely to rupture than fibrous plaques (14). Com- 
pared with persons without diabetes, patients with diabetes 
or hypertension, or both, appear to have a greater number of 
such fissured plaques (15). Despite a prepondernnce of lipid 
abnormalities in patients with diabetes, the independent 
contribution of total cholestetnl to coronary artery disease is 
approximately the same as that in patients without diabetes 
(16). The average total cholesterol evel in the Framingham 
study was 245 mg/dl and similar in patients with and without 
diabetes (17). Patients with diabetes have higher levels of 
very low density lipoprotein cholesterol WLDL) and trialyc- 
et’& and lower levels of high density lipoprotein tf?DL) 
cholesterol than do patients without diabetes, whereas levels 
of total and low density lipoprotein (LDL) cholesteml are 
not substantially different between the two groups (IS). The 
sfgnit?cance of the diabetic patient’s altered lipid prog:e as it 
relates to risk of coronary artery disease has not yet been 
defined. 
Hemat&sgfe sbnomtelii 6weebsg comnaq thrombosis. 
Occlusive thrombus formation is likely a dynamic process 
that depends on a balance between those factors that favor 
clotting and those that oppose it. In diabetes, abnomudities 
relating to platelet function, coagulation. fibrinolyris and 
endothelial function have been described that may favor 
intraluminal thrombosis at the site of plaque fissurina or 
rUpUU.E. 
Platelet aggregation is an essential step in wclusive 
thrombus fortnation. Recently, spontaneous platelet aggre- 
@ion has been shown to predict recurrent infarctinn after 
myocardial infarction (26). Spontaneous and induced platelet 
aaaregatian have been shown to be higher in patients with 
f27-3& than in patients without diabetes and correlate with 
so increase in cardiovascular events (27). Diabetic platelets 
seem to synthesize thmmhoxane As in ahnormally high 
amounts ml-341. a findina that would favor nlatelet aanre- 
@ion and vascuku spa& Elevated thrntnb& h&are 
mnst often found in diabetic p&tents with poor gfycemic 
control or vascular complications (29). Platelet consumption 
is higher in diabetic padents (29) and two platelet-specific 
pmteins, beta-thromboglobulin and platelet factor4, thought 
to reflect in viva pk&let activation, may be elevated in these 
patients W29k 
As mentioned, hypertension has been associated with an 
increased tendency toward plaque fissuring. a major precur- 
sor to myocardial infarction (IS) and hypertension is more 
common~in diabetic lhan in nondiabetic patients (16). It is 
found in Ml% of diabetic mtieni~ .45 years of ace (16X Its 
prevalence is especially high in diabedc want& and is a 
tiequent accompaniment o diabetic nephropathy. Cardio- 
vascular morndfty in diabetic nephropetby is up to 37 times 
that of the general population, probably at least in part 
because of the associated hypertension (19-7.1). 
Iiyperinsulinemia, particularly conunon in noninsulin- 
dependent diabetes mellitus with insulin resistance, appears 
The time of onset of acute ayocardia: infarction in 
diabetic and non&&tic p&ents has been shown to parallel 
the circadian variation in platelet reactivity in these patients. 
Whereas the population et large exhibits a prominent darn- 
ing increase in onset of Q wax infarction coincident .witb 
their period of greatest platelet agaregability (35). among 
diabetic patients Q wave infarction may occur more evenly 
throughout the day (3Sa). Platelet reactivity in diabetic 
patients has been shown to be elevated consistently through- 
out the day (361, an observation supporting the hypothesis 
that thls heightened platelet reactivity may have a causative 
mle in the increased iwdcncc of myocardial infarctloo in 
patients with diabetes. 
Plasma fibrinogen levels are elevated in diabetic patients 
(29,37) and have been shown to correla!e with myocardial 
infarcuor and sudden death in diabetic men (27). Factor VIII 
and factor VU1 ristocetin rofactor antigen are elevated in 
diabetic patients as well (25,27,29). Flbrinopeptide A reflects 
in viva thrombin activity and may also be elevated m 
diabelic patien:s (X.29,38). Endothelial dysfunction or dam- 
age in patients with diabetes results in deficient production 
of prostacyclin (29,39-41) and elevated levels of the proco- 
agulanr van Willebmnd factor (25,27,29). Endogenous fi- 
brinolysis has also been found to be deficient in these 
patients (29.37,38). 
Metabolic factors. Numerous studies have examined the 
relation of type of therapy for diabetes to both the extent of 
coronary artery disease and Ihc ouwxne after acute myo- 
cardial infarction. The majority of these studies indicate that 
treatment with oral hypoglycemic agents or insulin is wo- 
ciated with a poorer prognosis (42-47) and more extensive 
coronary disease than those of diabetes controlled by diet 
alone (48.49). Elevated clvcosvlated hemoelobin levels. 
which reftect inadequate l&&m glycemic;ontrol, have 
also been shown to be associated with a higher mortality rate 
after infarction (46). Despite the evidence that poor long 
term glycemic control is associated with a negative outcome. 
no study has convincingly demonstrated that improved 
glycemic control leads to better clinical outcome. 
Role of aulonomic neuropathy. The development af 
symptomatic autonomic neuropathy in diabetic patients is 
associated wth a mortality late-of up to 50% 3 ye& after its 
onset (501. Sudden, possibly cardiac. death is resoonsible for 
up to 33% of thesk deathi (SO). Cardiac p&ympathetic 
nerve fibers are affected before sympathetic fibers, leading 
initially to a relative increase in sympathetic tone that results 
in tachycardia at rest and attenuation of the expected in- 
crease in heart rate and blood pressure with exercise (5 I ,52). 
An absence ofparasympathetic tone may also be responsible 
for exaggerated or inappropriate coronary vasoconstriction. 
which may produce or wouen ischemia. Sympathetic ner- 
vow system dysfunction is usually evident within 5 years of 
the diagnosis of parasympathetic dysfunction. The principal 
clinical manifestation of sympathetic dvsfunction is oostural 
hypotension. Autonomic oeiropathy thus may lead’to isch- 
emia or infarction by several routes: increasing myacardial 
oxygen demand by increasing heart late at rest, reducing 
myocardial blood flow by inricaaing ‘rronary vascular tone 
at the site of a coronary stenosir, re!lucing coronary perfu- 
sion pressure during onhostatic hypotension (53) and clim- 
inatinr: early warning signs of ischemia. 
Autonomic neuroporky and morbidiry during general 
onerrhesia. The importance of intact autonomic function 
during cardiovascul& stress (a3 in a myocardial infarction) is 
exemplified in diabetic patients undergoing general anesthe- 
sia. Burgos et al. 154) found that 35% of diabetic patients 
compared with onlv 5% of nondiabetic patients required 
vasopressor suppon tp < 0.05). The increased morbidity in 
diabetic patients experiencing general anesthesia may be due 
to inability to counteract the hemodynamic effects of induc- 
tion of anesthesia because of impaired cardiovascular re- 
flexes (54). Diabetic patients who required vasopressor 
soppon had significantly greater autonomic impairment than 
did those patients who did not. 
Auronomic nerrrooarkv and sadden death. In addition, 
autonomic neuropatiy miy be responsible for sudden death 
in diabetic oatients (55-591. Althoueh some of these sudden 
deaths ma; be due to arrhythmia secondary to a silent 
myocardial infarction, autopsy studies have demonstrated a 
surprising absence of significant coronary artery disease in 
some diabetic patients experiencing sudden death (56,60). A 
relation has been noted between diabetic cardiac autonomic 
neuropathy and prolonged QT interval on the electrocardio- 
gram (ECG) (57-59.61). which may predispose to lifee- 
threatening ventricular arrhythmia. Diabetic patients with 
autonomic neuropathy have been found to have a relative 
decrease in vagal tone (thus a relative increase in sympa- 
thetic tone) at the same time of day when the frequency of 
sudden death has been ranted 10 be uarticularlv hieh (62). 
It has been proposed that the combination oi reiatively 
heightened sympathetic tone or QT interval txolotwation. or 
both, might increase the likelihood of arrhythmias leading to 
sudden death (61.62). 
Altered perception of iahemia. Diabetic patients have a 
blunted appreciation for ischemic pain. As a result of this 
reduced sensation, myocardial ischemia or infarction may be 
associated with only mild symptoms and go unrecognized or 
may be entirty asymptomatic and thus truly silent. Al- 
thcdgh 25% of the myocardial infarctions in the Framingham 
study were unrecognized, symptoms referable to infarction 
could be elicited in nearly 50% ofthese cases. The remaining 
infarctions (or approximately 12% of the total number) were 
believed to be truly asymplomatic. Unrecognized infarction 
tends to be more common in diabetic patients (63). and 
comprises 39% of their infarctions compared with 22% of 
those in nondiabetic patients (64). Although there has beena 
general trend towrd a higher prevalence of silent infarction 
in diabetic patients, conclusive proof of this pixnomenon 
has been hindered by the limited statistical power of most 
studies. These data parallel the observation that myocardiat 
scar in the absence of an antemonem history of infarction is 
three times more commonly found at autopsy in diabetic 
than in nondiabetic patients (65). 
As might he inferred from the preceding data, diabetic 
paticnts may also lack angina duiug myucardial ischemia. 
The incfdence of painless ST depression during exercise 
tolerance tests is almost double that seen in nondiabetic 
padents (69% vs. 35%) and is related to severe autonomic 
neuropathy (66). Nesto et al. (67) demonstrated that diabetic 
patients experience angina less commonly than do nondia- 
betic patients during ischemia on thallium exercise testing. 
Diabetic patients who do experience angina become aware 
of their symptoms later in the coarse of ischemia than do 
nondiabetic patients 1681. ‘The delay m tone from the onset of 
ST segment depression to angina may be twice as long m 
diabetic as in nondiabetic p&en& and care&, wLi rho 
extent of autonomic nervous dysfunction (681. Neuropathy 
of &rent autonomic pathways may also indicate damage to 
a&rent autonomic fibers responsible for the transmwion of 
sensory impulses relating to perceptton of myocardial isch- 
emia. Histologic damage to cardiac &rent nerve fibers 1691. 
as well as physiologic evidence of afferent and efferent nerve 
damage (55,70.7lL has been shown in diabetic pauents. 
suggesting that neuropathy involving these fibers exist, and 
may play a role in blunting ischemic pain. 
Role of aiypicsl presenting symptoms. The diabeuc pa- 
tient’s abnormal perception of myocardial ischemia may lead 
to atypical or less impressive symptoon of myocardial 
infarction than are seen in the nondiabetic patient. Accurate 
diagnosis of infarction based on historical grounds may 
therefore be difficult. Atypical symproms such as confusion. 
dyspnea. fatigue ornaoseaand vomiting may be the presenr- 
ine camolaint in 32% to 42% of diabetic oatients with 
myocard~al infarction compared with 6% to 15% of nondia- 
betic patients (72). In some cases such symptoms may mim:c 
those associated with either hypoglycemia or hyperglyce. 
mia. which can cause delay in triaging the patient. The 
atypical presenting symptoms seen in the diabetic patient 
may lower the clinician’s suspicion of infxc:ion. ‘eadinp to 
les; than optimal care. Sole; et al. (43) found that 357; of 
diabetic patients with acute rnyocardial infarction were 
admitted initially to the general wards rather than to the 
coronary care unit. More than 75% of those diabetic patients 
assigned to ward care lacked typical chest pain. whereas 
nearly all of those admitted to the coronary care unit had 
severe chest pain. A comwiron of the ECG at mesentation 
with a prior tking may tk extremely helpful in~establishing 
a diagnosis when a patient with suspected acute myocardial 
infarction has no typical symptoms. 
Atypical symptoms may alter the patients’ perception of 
the nature of their illness and interfere with their decision to 
seek medical care. An association has been noted between 
nonpainful myocwdij ;/ idrctice and iscreased zrdiac mor- 
bidity and mortality (73.74). Uretsky et al. (73) examined a 
group of diabetic and nondiabetic patients in whom acute 
myoardial infarction was associated with atypical symp- 
toms. These patients were older than patients with more 
classic symptoms and most had no history of prior angina. 
They did not seek medical care until a mean of I2 h after the 
onset of symptoms and ~33% waited ~-24 h. Cardiogcnic 
shock was seen in 35% of patients with atypical presenting 
symptoms and the hospital mortality rote was 50% It seems 
likely that the delay in receiving appropriate care may 
contribute to the observed increase in morbidity and mor- 
Course of Acute Myocardial Inarction 
In the immediate peri-infarction period. moTtality is cs- 
pecidly high in diabetic patients. In one study 175). :he 
In-howlal mortality rate of diabetic oatienrs expaiencinc a 
mvocardial infarction was 28%. Tbi- rate was 18% in [h&e 
w!~h a host mfarction but increzscd substantially to 418 in 
thovz with a prior infarction. Approximately 5a of patients 
presenting with acute myocardial infarction have previously 
undiagnoxd diabetes mellitus. These patients hare the poor 
prognoses of the previously diR:-?sed diabetic patients with 
acute mfarcrion (46). 
Diabetic women have a poorer prognosis than do diabetic 
men and newly twice the in hospital mortality rate (75). In 
one study 176) the increxed mortality seen in women was 
attnbuted to their high incidence of severe congestive heart 
failure and cardiogenic shock. The etiology of the increased 
frequency of co&stive heart failure did shock among 
women is not kown. Obese diabetic women may be at 
particular risk: this group had an in-hospital moriality rate of 
43% in one study (77). 
In contrast to younger patients without diabetes. who 
gcncrally seem to tolerate infarction better than the elderly, 
younger diabetic patients constitute a particularly high risk 
group: Czyzk et al. (78) found that diabetic patients between 
the ages of 45 and M years have a particularly increased 
mortality rate compared with that of nondiabetic patients of 
similar age with acute myocardial infarction. Singer and 
colleagues 17Y) also found that younger diabetic patients with 
a low baseline risk profile had the greatest relative mortality 
risk fmm myocardial infarction. 
Complications of infarction. Diabetic patients sustaining 
a myocardial infarction are more likely than nandiabetic 
patients to encounter complications. Recurrent infarction, 
cardiogenic shock, atrioventtiular and intraventricolar con- 
duction abnormalities. chronic congestwe heart failure and 
myocardial rupture are all more common in the diabetic than 
in the nondiabetic patient (44.45.78,80,81). In sddition. some 
studies have found anterior infarction to be more common 
l45.79.82). and this may partially explain their overall poorer 
prognosis. Anterior transmural myocardial infarction in one 
study was associated with a 46% 3@day mortality rate in 
diabetic patients (79). 
in oider studies. clinically significant (class 111 or IV) 
congestive heartfailure develbpedin4l%ofdiabetic women 
and 25% of diabetic men (75) and was believed 10 be the 
cause of death in 22% ofdiabetic women and 6% of diabetic 
men with acute myocardial infarction (75). The increased 
incidence of congestive failure in patients with diabetes, and 
in dlabetlc worn&t in particular, is seen even though infxt 
size is similar in patients with and without diabetes (76). This 
increase in congestive heart failure ofcurs even though 
diabetic and nondiabetic patients also have similar valoes for 
left ventricular ejection fraction (45). Several factors inay be 
responsible for these observations. Diabetic patients are 
likely to have antecedent hypertension, which may Impair 
systohc or diastolic function, or both. The presence of 
autonomic dysfunction may also impair reflex adaptation to 
hemodynamic stress imposed by infarction. The greater 
extent of coronary artery disease in the diabetic patient 
mi&t also limit the availability of collateral blood Row to the 
infarct zone, thus unpairing some of the functional recovery 
atforded by restored blood Row to the infarcl zone. 
Diabetic cardiomyopathy. Congestwe heart fatlure out of 
proportion to myocardial infarct size could also be due in 
part to eoneomitant subclinrcal diabetic cardiomyoplby 
(83). In the absence of coronary disease. diabetic patients 
may have abnormalities of systolic and diastolic left ventric- 
ular function termed “diabetic cardiomyopathy” (4X84- 
88), which differs from the “ischemic cardiomyopathy” due 
to multiple infarctions. Pathologic findings in diabetic car- 
diomyopathy include myocardial enlargement, hypertrophy 
and ftbrosis as welt us an increase in basement membrane 
thiekanina with periodic aeidSchiff-positive deposits in the 
interstitium and microaneurysm formation (84.89-92). Inter- 
stirial deposits, microvascular disease and abnormal calcium 
uptake by sarcoplasmic reticulum are potential causes of the 
physiologic abnormahties just noted (83.87). The coexis- 
tence of hypertension with diabetes may result in more 
marked interstitial scarring, dilation and hypertrophy than 
are present with either condition alone (92-94). thus aug- 
menting the functional ahnonnalities seen in diabetic cardio- 
myopathy. 
Because diabetic cardiomyopathy occurs in the absence 
of coronary disease, it is unlikely that it is directly involved 
in the pathogenesis of acute or recurrent myocardial infure- 
tion in diabetic patients. Diabetic cardiomyopathy may 
indirectly predispose to myocardial infarction by increasing 
wall tension secondary to myocardial dilation or by further 
impairing myocaniial perfuston at the n~icrovascuiar level in 
a r&n distal to an epicardial coronary stenosis or occlu- 
sion. Acute myocardial infarction supetimposed on a sub- 
strate of preexisting diabetic cardiomyopathy may then 
further increase w: II stress and contribute too more morbid 
enurse after infarction. 
Diabetic ntc’abuliem and outcome after infarction. In ad- 
dition, metabolic responses to iscbemia peculiar to the 
diabetic patients could affect contractile performance. Un- 
der conditions of myocardial ischcmia, glycemic control 
becomes particularly importam. During ischcmia the heart 
shifts from aerobic metabolism with Primary use of fatty 
acids to anaerobic metabolism, which depends on glucose as 
an energy source. Glucose transport into cells is therefore 
crucial. Insulin favors glucose uptake, whereas ketones, 
high levels of free fatty acids and their oxidation producls. 
found during insulinopenia, inhibn its transmembrane move- 
men!. Catecholamine excess, often present with infarction, 
may further worsen myocardial metabolism in the diabetic 
patient by decreasing insulin secretory reserve and favoring 
lipolyhis and myocardial free fatty acid uptake. There is 
smte evidence that free fatty acids may be toxic to myocar- 
dial cells (95). Studies have shown that elevated plasma 
glucose levels during myocardial infarction may be associ- 
ated with a nom outcome after mfarction (43,44,46). These 
da:a roust be interpreted with caution because hyperglyce- 
mia or diabetic ketoacidosis may be the result of increased 
adrenergic tone due to more extensive infarction. Diabetic 
kelnacidosis occurs in approximately 4% of infarctions in 
diabetic patients (75) and may be the presenting symptom. 
When diabetic kctoacidosis complicates infarction, mortality 
is higher and may approach 85% (96). 
Major risk fuetors. The increased in-hospital mortality 
rete in diabetic patitnt~ with infarction in one study was 
found to occur durina davs 2 to 7 of the hosoital stav. Durine 
this period the mort&y~rate was more than three timer that 
of nondiabetic patients and was seen mostly prominenlly in 
patients with insulin-dependent diabetes (78). Much of the 
excess mortality during this interval was due to congestive 
heart failure. although arrhythmias and condur_tian abnor- 
malities were sinnificant contributors as well. In this studv. 
diabetic patientswith arrhythmias. second- and third-degree 
alrioventricular (AV1 block and left bundle branch block 
experienced a 47% in-hospital mnrtality rate-three times 
that of snnilru ptuicnts without diabetes (713). Some but not 
all studies (47.Y7) have documented an increaSe in AV (44) 
and introventricular (45) conduction abnormalities in dia- 
betic patients. Four prognostic variables in the immediate 
period after acute myocardial infarction in diabetic patients 
have been found to be independent predictors of poor 
prognosis. In order of descending importance they were 
I) Q wave acute myocardial infarction, 2) prior acute ntyo- 
cardial infarction, 3) female gender, and 4) insulin treatment 
before hospital admission (75). Obesity and anterior locution 
of inter&n are also associated with poor prognosis in 
diabetic patients (45). 
Late Cardiac Complications and Mortality 
Role of persistent teehernia. The presence of diabetes 
mellitus is an independent predictor of cardiac mortality, 
which ranges from 26% to 62% in the 1st year after myocnr- 
dial infarction and may reach 7% by 5 years (42.45,98). 
Immediate postinfarction morbidity and mortality is usually 
due lo congestive heart failure, cardiogenic shock or eon- 
duction disturbances. Patients survivingthese complications 
suffer from recurrent nonfatal (99) and fatal myocardial 
infarction to a greater degree than do nondiabetic patients. 
One explanation for the increased morbidity and mortality 
may be persistent ischemia or ongoing myocurdial damage 
after infarction. Technetium pyrophosphate scintigtaphy has 
been performed in diabetic and nondiabetic tatients in the 
acule~phase and 3 months after myocardial iufarclion (100). 
Sixty-two percent of diabetic patients were found to have a 
persistently positive technetium pyrophosphate seun at 3 
months compared with only 12% of nondiabetic patients. 
More frequent complications after hospital discharge, in- 
eluding congestive heart failure.recurrent myocardial infarc- 
tion and death, were seen in both diabetic and nondiabetic 
patients with chronic technetium pyrophosphate uptake. 
Diabetic patients with chronic technetium pyrophosphate 
uptake exhibited marked myocardial myacyrolyc~s m au- 
topsy, signifying ongoing myocardial necrosis 
Risk feetors for future eardiae events. As in the nondia- 
hetic patient, certain characteristics denote patients at high 
risk for future cardiac events. Prognostic indicators associ- 
ared wtth a poor utcome after hospital discharge at patw~ts 
who smvive the coronary care unit phase of ho~pitabratian 
include: I) cardiac symptoms for at least I month bcfure the 
infarction. 2) pulmonary r&s during the initial phase of the 
hospital stay, 3) >I0 ventricular premature heatslh heforc 
hospital discharge. and 41 at least moderately reduced left 
ventricularejection fraction (<40%) by radionuciide ventric- 
ttlography (42). 
Management Considerations 
Although there are few data analyzing eti?sacy of therapy 
in diabetic patients as a subset. there are theoretic grounds 
for anticipating that certain therapies may he particularly 
useful in the patient with diabetes. Management of the 
diabetic patient with acme myocardial infarction is. for the 
most part, similar to that of the nondiabetic pntient. wit.> 
certain special considerations. 
Thrombolysis. Tbrombolytic therapy for myocardial in- 
farction has proved value in patients presenting solo after 
the onset of infarction who demonstrate ST segment eleva- 
tion on the ECG. The atypical symptoms seen m diabetic 
patients may not only cause delay in seeking medical care 
perrtttaneotts transluminZl coronaly angioplasty. Corooary 
artery bypass grafting is as effective in relieving angina1 
rympWm5 m diabetic patients as in nondiabetic paticnt5, 
although the long-term survival rate after bypass surgery 
remains consistently lower in diabetic than in nondiabetic 
patients II@4 105). Diabetic patients may require more hy- 
pass grafls because of their more extensive atherosclerosis 
I WI. However. lam graft paRacy in these parienrs is similar 
to that of nondiabetic patients 1105). Perioperative mortality 
app+zars tobe elevated in the diabetic patient-4.5% to 5.1% 
compared wth 2.5% in patients without diabetes (104). Poor 
stcrnotomy healing. renal failure and prolonged length of 
horpitaiization are more common in diabetic patients (104). 
Percutaneous transluminal coronary angioplasty is an 
effective tool to relieve ischemic symptoms in diabetic 
patients with suitable coronary anatomy. .4ltbowb few data 
exist relating to coronary &iopb&on diabetics specbi- 
catty in the acme infarction setting. it appears that diabetic 
patients may be somewhat more prone than nondiabetic 
patients t 106) to restenosis after angioplasty. Diabetes is also 
an independent variable predicting resteoosis after a second 
coronary angtoptasty ar a given site (107). In multivessel 
coronary angioplasty. diabetes is associated with a lower 
primary success rate and a hi&r rme of complications 
C 108). Despite possible shortcomings. coronary artery angia- 
plasty is an attractive treatment option due to its low 
morbidity and brief convalescetre period and avoidance of 
the potential problems associated with bypass surgery. 
but make i difficult to determine the time of onset of 
infarction. These facton peculiar to the diabetic patient may 
Secondary Prevention After Myocardial 
interfere with the decision to initia!e thromholytic therapy. Infarction 
Denying treatment with a thmmbolytic agent on this basis is Beta-adrenoreeqlor block&. The “se of beta-blockers 
tmfonttttate because the decrease in mortality with thmm- has been shown to favorably affect mortality following 
bolysis in these patients is at least equal to that seen in myocardial infarction. In the Timolol in Myocardial Iafarc- 
patients without diabetes (101). A recent reanalysis (102) of tion study (IO!+. administration of timolol (a nonbeta- 
prior data suggests that 1:~ bcseEt of thi;-mhcli.!ic treelment :elective agent) was associmed with a substantial reduction 
may be greatest in high risk subgmups such as patients with in overall mortality including total cardiac death, sudden 
diabetes. A high incidence of hemorrhagic complications death and nonfatal reinfarcti~n The magnitude of risk re- 
associated with increased mortality has been reported (I031 duction for cardiac death and nonfatal reinfarction was 
in diabetic patients >75 years of age. Thus. thmmholysis in particularly great in diabetic patients, suggesting an even 
elderly diabetic patients should probably b-e limited to those greater benefit ofbcta-blockade in this group than in patients 
with Me-threatening myocardial infarction until further data without diabetes. Timolol was tolerated equally well in 
clarify whether the benefits in this group outweigh the risks. patients withand without diabetes. Anotherstudyexamining 
Although one might presume that the presence of prolifera- beta-blocker use in 281 diabetic patients after acute myocx- 
tive retinopathy would represent B relative contraindication dial infarction found a decrease in mortality from 17% to 
to the use of tbmmholytic agents in many diabetic patients. 10% at I year after hospital discharge (I IO). In multivariate 
retinal hemorrhages were not seen in the I21 diabetic pa- analysis in the same study. beta-blocker use was found to be 
tients treated with thromholytic agents in the Thrombolysis an independent predictor of cardiac survival at I year in 
and Angioplasty in Acttte Myocardial Infarction (TAMI) trial dtabetic patients, whether or not pulmonary congestion was 
(101). present on the admission chest X-my film. 
Invrvsive management. Diabetic patients with acme myo- The potential benefits of beta-blockerr are counterbat- 
cardial infarction who manifest signs of ongoing &hernia awed by adverse effects peculiar to the diabetic patient. 
despite medical therapy should be considered for myocardial These agent? may attenuate reflex tachycardia, mask “wara- 
revasculatization by coronary artery bypass grafting or ing” symptoms due to hypoglycemia and potemiate insulin- 
induced hypoglycemia by inhibi!ing glycogenolys~s. For 
these reasons. many clinicians have been reluctant to use 
beta-blockers in diabetic patients. On the contrary. beta- 
blockers are usually well tolerated and may be of parlicular 
benefit in the diabetic patient despite these concerns. Many 
of the complications seen with beta-blocker administration 
mentioned are encountered with doses higher than that 
which may be needed to provide secondary protection 
against cardiac death. 
Aspirin. Aspirin has sranificant moved value aiter myo- 
cardial infarction m nondiabedc p&r& reduang the r&e 
of short-term mortalitv and reinfarction II I I). Diabetic va- 
tients have a height&d platelet reactivity 127-30) that I& 
play a role not only in the accelerated progression of 
atherosclerosis. but also in the development of occlusive 
thrombus formation at the site of coronary plaque rupture. 
Thus, it is likely that aspirin may be even more !xebl in 
patients with than in patients without diabetes because of 
this baseline increased platelet activity. Studies regarding 
primary and secondary prevention of myoeardial infarction 
in diabetic patients have zot been performed and would be 
clinically useful. 
Tber~ has been some concern. however, that aspirin may 
potentiate the develonment of retinal hemorrhage in diabetic 
patients. The safety- of long-term aspirin use in diabetic 
patients with early retinopathy has been demonstrated in the 
DAMAD study (I121 in which aspirin (325 mg three times 
daily) was administered 10 267 diabetic patients with early 
retinnpathy with a decrease in retinal microtmeurysms wilh- 
out a single case of worsening retinal hemorrhage ill:!). 
These data may not apply to diabetic patients with rr.om 
severe demees of retinauathv in whom the safetv of aroirin 
has not yet been determ% 
. 
Risk factor modification. Attention must also focus on 
risk factor modification to reduce progressive athemsclero- 
sis and the risk of reinfarction. Hypenension should he 
controlled. preferably wth agents tailored to improve any 
systolic or diastolic Icft ventricular dysfunctmn. Hyperlipi- 
demias and obesity should be managed aggressively. Sec- 
ondary prevention efforts with risk factor modification may 
be most justified in diabetic women who experience a 
particularly high late cardiac mortality rate after surviving 
myocardial infarction (45,77). 
Cigarette smoking is an impartant factor that promotes 
coronary atherosclerosis. Diabetic patients are as hkely as 
the general public to be smokers (I 13). Cigarette smoking is 
an independent predictor of mortality in patients wth insu- 
lin-dependent diabetes and is particularly dangerous in dia- 
betic women with insulin-dependent diabetes. because it 
more than doubles their risk of cardiac mortality (I 13). 
Conclusions 
Diabetes mellitus is associated with an increased morbid- 
ity and mortality related to coronary artery disease. In 
addition to acceleiated atherosclerosis. multiple dynamic 
factors related to diabetes not only predispose to acute 
myocardial infarction but also contribute to posrinfarctmn 
complications. Furlher understanding of the impact of dia- 
betes on the pathophysiology of acute myocardial infarction 
may lead to more specialized treatment modalities for lhis 
high risk subgroup. 
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